A

Artrya Ltd
ASX:AYA

Watchlist Manager
Artrya Ltd
ASX:AYA
Watchlist
Price: 3.94 AUD 1.81% Market Closed
Market Cap: 622.8m AUD

EV/EBITDA
Enterprise Value to EBITDA

-36.8
Current
-6
Median
11.9
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-36.8
=
Enterprise Value
611.6m AUD
/
EBITDA
-16.6m AUD
All Countries
Close
EBITDA Growth EV/EBITDA to Growth
AU
A
Artrya Ltd
ASX:AYA
Average EV/EBITDA: 71.6
Negative Multiple: -36.8
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
33.4
39%
0.9
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
146.9
32%
4.6
JP
M3 Inc
TSE:2413
17.1
14%
1.2
US
Doximity Inc
NYSE:DOCS
28.7
23%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
17
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -125.8 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
74.4
80%
0.9
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
34.5
24%
1.4
US
V
Vocera Communications Inc
F:V00
270.9
N/A N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
hidden
2-Years Forward
EV/EBITDA
hidden
3-Years Forward
EV/EBITDA
hidden